Hermann Lübbert
Chief Executive Officer chez BIOFRONTERA INC.
Fortune : 16 078 $ au 31/03/2024
Profil
Hermann Lübbert was the founder and had founded Biofrontera AG in 1997, where he held the title of Chairman-Management Board & CEO until 2021.
He currently holds the position of Chairman & Chief Executive Officer at Biofrontera, Inc. since 2015.
He is also the Co-Managing Director at Biofrontera Bioscience GmbH and a Professor at Ruhr-Universität Bochum.
In the past, he served as Co-Managing Director at Biofrontera Pharma GmbH and as a Member at Novartis Pharma AG.
Dr. Lübbert obtained his doctorate degree from Universität zu Köln in 1984.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BIOFRONTERA, INC.
0,21% | 03/11/2023 | 10 440 ( 0,21% ) | 16 078 $ | 31/03/2024 |
Postes actifs de Hermann Lübbert
| Sociétés | Poste | Début |
|---|---|---|
| BIOFRONTERA INC. | Chief Executive Officer | 26/05/2023 |
| Ruhr-Universität Bochum | Corporate Officer/Principal | - |
Biofrontera Bioscience GmbH
 Biofrontera Bioscience GmbH Financial ConglomeratesFinance Part of Biofrontera AG, Biofrontera Bioscience GmbH is a German commercial biotech company that provides high-quality treatment options in photodynamic therapy and topical antibiotics. The private company is based in Leverkusen, Germany. The CEOs of the company are Thomas Schaffer, Hermann Lübbert. | Chief Executive Officer | - |
Anciens postes connus de Hermann Lübbert
| Sociétés | Poste | Fin |
|---|---|---|
| BIOFRONTERA AG | Chief Executive Officer | 13/12/2021 |
Biofrontera Pharma GmbH
 Biofrontera Pharma GmbH Miscellaneous Commercial ServicesCommercial Services Part of Infinity Pharmaceuticals, Inc., Biofrontera Pharma GmbH is a German company that provides natural products drug discovery services. The company is based in Leverkusen, Germany. The CEOs are María del Pilar de la Huerta Martínez, Montserrat Foguet. The private company was founded in 2003. Biofrontera Pharma was acquired by Discovery Partners International, Inc. from Biofrontera AG on June 30, 2005. | Chief Executive Officer | - |
Novartis Pharma AG
 Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
Formation de Hermann Lübbert
| Universität zu Köln | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| BIOFRONTERA AG | Health Technology |
| BIOFRONTERA INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Biofrontera Pharma GmbH
Biofrontera Pharma GmbH Miscellaneous Commercial ServicesCommercial Services Part of Infinity Pharmaceuticals, Inc., Biofrontera Pharma GmbH is a German company that provides natural products drug discovery services. The company is based in Leverkusen, Germany. The CEOs are María del Pilar de la Huerta Martínez, Montserrat Foguet. The private company was founded in 2003. Biofrontera Pharma was acquired by Discovery Partners International, Inc. from Biofrontera AG on June 30, 2005. | Commercial Services |
Novartis Pharma AG
Novartis Pharma AG Pharmaceuticals: MajorHealth Technology Novartis Pharma AG engages in the research in as well as the production and distribution of pharmaceutical, chemical, medical, and biotechnological products. It also provides related services. The company was founded on October 25, 1989 and is headquartered in Basel, Switzerland. | Health Technology |
Biofrontera Bioscience GmbH
Biofrontera Bioscience GmbH Financial ConglomeratesFinance Part of Biofrontera AG, Biofrontera Bioscience GmbH is a German commercial biotech company that provides high-quality treatment options in photodynamic therapy and topical antibiotics. The private company is based in Leverkusen, Germany. The CEOs of the company are Thomas Schaffer, Hermann Lübbert. | Finance |
